Literature DB >> 1681404

Rat striatal and mesencephalic neurons contain the long isoform of the D2 dopamine receptor mRNA.

C Le Moine1, B Bloch.   

Abstract

Cloning of the D2 dopamine receptor gene has demonstrated that two D2 mRNA isoforms are generated through alternative splicing: a short mRNA (D2(415)) and a long one (D2(444)) that differs by an additional exon transcript. D2 receptor gene expression was demonstrated in striatal dopamine terminal fields as well as in the mesencephalon by in situ hybridization using a probe that does not differentiate the two isoforms or a probe specific for the D2(444)) mRNA. We report here that the long D2(444)) mRNA isoform is present in all the neurons expressing the D2 receptor gene in the striatum and the mesencephalon. In the striatum, medium-sized neurons (previously identified as enkephalinergic) and large-sized neurons (previously identified as cholinergic) contain the D2(444)) mRNA. Our results with the D2(444)) probe confirm that 20% of the cholinergic neurons in the striatum do not express the D2 gene. The present results also demonstrate that the neurons expressing the D2 receptor gene in the substantia nigra are dopamine neurons and that D2 mRNA can be present in proximal dendrites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681404     DOI: 10.1016/0169-328x(91)90086-d

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  4 in total

1.  Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.

Authors:  S J Cragg; S A Greenfield
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Dopamine D1 and D3 receptor interactions in cocaine reward and seeking in rats.

Authors:  E Galaj; W Harding; R Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2016-08-31       Impact factor: 4.530

3.  Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.

Authors:  Steven P Presgraves; Tariq Ahmed; Sabine Borwege; Jeffrey N Joyce
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.978

4.  Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.

Authors:  Jeffrey N Joyce; Cheryl Woolsey; Han Ryoo; Sabine Borwege; Diane Hagner
Journal:  BMC Biol       Date:  2004-10-11       Impact factor: 7.431

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.